Measure | N | M (SD) | Mdn (IQR) | Range | Mann-Whitney U (positive vs. negative) | ||
---|---|---|---|---|---|---|---|
Z | p | Cohen’s d | |||||
Sleep latency (min) | |||||||
SRBD | |||||||
Positive | 15 | 40.00 (20.96) | 30 (30–60) | 15–90 | 1.11 | .266 | 0.23 |
Negative | 81 | 34.49 (21.69) | 30 (18.5–45.0) | 5–90 | |||
Sleepiness | |||||||
Positive | 21 | 34.38 (17.51) | 30 (17.5–48.5) | 10–60 | 0.70 | .486 | 0.08 |
Negative | 49 | 32.82 (21.86) | 30 (16–45) | 10–90 | |||
Nighttime sleep duration (hr) | |||||||
SRBD | |||||||
Positive | 15 | 10.05 (1.29) | 10.5 (9–11) | 7.5–12.3 | 0.83 | .405 | 0.17 |
Negative | 81 | 10.42 (1.05) | 10.5 (9.8–11) | 7.3–13.3 | |||
Sleepiness | |||||||
Positive | 21 | 10.50 (1.22) | 10.5 (9.6–11.4) | 8.3–13.3 | 0.07 | .944 | 0.01 |
Negative | 49 | 10.51 (0.94) | 10.5 (10–11) | 8.3–12.5 | |||
CBCL DSM-5-based scales | |||||||
Depressive Problems T | |||||||
SRBD | |||||||
Positive | 15 | 67.73 (6.02) | 67 (63–72) | 56–77 | 5.13 | < .001* | 1.21 |
Negative | 81 | 56.21 (5.22) | 56 (51–60) | 50–70 | |||
Sleepiness | |||||||
Positive | 21 | 61.29 (8.44) | 60 (54–67) | 50–77 | 2.45 | .014 | 0.86 |
Negative | 49 | 55.90 (5.13) | 56 (51–60) | 50–67 | |||
Anxiety Problems T | |||||||
SRBD | |||||||
Positive | 15 | 52.60 (3.96) | 51 (50–54) | 50–60 | 2.13 | .033* | 0.37 |
Negative | 81 | 51.15 (2.35) | 50 (50–51) | 50–60 | |||
Sleepiness | |||||||
Positive | 21 | 50.90 (2.28) | 50 (50–51) | 50–60 | 0.20 | .843 | 0.05 |
Negative | 49 | 51.02 (2.29) | 50 (50–51) | 50–60 | |||
Autism Spectrum Problems T | |||||||
SRBD | |||||||
Positive | 15 | 59.47 (7.38) | 58 (54–61) | 51–79 | 2.63 | .016* | 0.50 |
Negative | 81 | 55.74 (7.14) | 54 (51–58) | 50–87 | |||
Sleepiness | |||||||
Positive | 21 | 58.05 (8.66) | 58 (51–61) | 50–87 | 0.76 | .448 | 0.27 |
Negative | 49 | 56.12 (6.44) | 54 (51–61) | 50–70 | |||
Attention/Hyperactivity Problems T | |||||||
SRBD | |||||||
Positive | 15 | 62.87 (6.42) | 64 (57–67) | 54–76 | 4.27 | < .001* | 0.95 |
Negative | 81 | 54.64 (5.97) | 52 (50–51) | 50–76 | |||
Sleepiness | |||||||
Positive | 21 | 60.71 (7.04) | 60 (55.5–65.5) | 51–76 | 4.50 | < .001* | 1.21 |
Negative | 49 | 53.41 (5.53) | 51 (50–54) | 50–76 | |||
Oppositional Defiant Problems T | |||||||
SRBD | |||||||
Positive | 15 | 56.80 (9.07) | 52 (50–64) | 50–77 | 2.77 | .006* | 0.53 |
Negative | 81 | 51.30 (2.81) | 50 (50–51) | 50–64 | |||
Sleepiness | |||||||
Positive | 21 | 54.33 (6.77) | 51 (50–57) | 50–70 | 2.02 | .043 | 0.79 |
Negative | 49 | 51.12 (2.12) | 50 (50–52) | 50–59 | |||
CBCL 2007 Scale | |||||||
Stress Problems T | |||||||
SRBD | |||||||
Positive | 15 | 61.27 (10.41) | 63 (53–67) | 51–85 | 3.87 | < .001* | 0.83 |
Negative | 81 | 53.00 (4.12) | 51 (50–53) | 50–70 | |||
Sleepiness | |||||||
Positive | 21 | 56.81 (8.61) | 53 (51–60.5) | 50–85 | 2.87 | .004* | 0.66 |
Negative | 49 | 52.92 (4.37) | 51 (50–53) | 50–70 | |||
CBCL Higher-order Factor Scales | |||||||
Internalizing Problems T | |||||||
SRBD | |||||||
Positive | 15 | 56.80 (6.39) | 59 (51–60) | 45–68 | 3.14 | .002* | 0.67 |
Negative | 81 | 49.48 (7.94) | 47 (45–55.5) | 29–66 | |||
Sleepiness | |||||||
Positive | 21 | 51.43 (8.77) | 51 (47–58.5) | 33–68 | 1.04 | .300 | 0.21 |
Negative | 49 | 49.67 (8.04) | 47 (45–56) | 29–64 | |||
Externalizing Problems T | |||||||
SRBD | |||||||
Positive | 15 | 61.20 (9.40) | 58 (54–65) | 47–80 | 4.51 | < .001* | 1.03 |
Negative | 81 | 47.48 (8.31) | 46 (40–54) | 31–67 | |||
Sleepiness | |||||||
Positive | 21 | 57.00 (9.92) | 56 (50–61) | 39–80 | 4.09 | < .001* | 1.22 |
Negative | 49 | 46.49 (7.97) | 46 (40–51.5) | 32–64 | |||
Total Problems T | |||||||
SRBD | |||||||
Positive | 15 | 62.67 (5.82) | 62 (57–66) | 55–73 | 5.19 | < .001* | 1.25 |
Negative | 81 | 49.33 (7.40) | 50 (43–55) | 31–65 | |||
Sleepiness | |||||||
Positive | 21 | 56.81 (8.07) | 57 (53–61) | 40–73 | 3.81 | < .001* | 1.13 |
Negative | 49 | 48.33 (7.30) | 50 (43–53.5) | 31–65 |